reports
XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, A...
XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024 Webcast and Conference Call Scheduled for 5:00 PM ET NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report results for the year ended December 31, 2023, on Tuesday, April 16, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast ...
Solid Power Announces Upcoming Investor Conference Schedule
Solid Power Announces Upcoming Investor Conference Schedule LOUISVILLE, Colo., April 16, 2024 (GLOBE NEWSWIRE) -- , Inc. ("Solid Power") (Nasdaq: ), a leading developer of solid-state battery technology, today announced it will participate in the following investor conferences in the coming months: Janney Fireside ChatPresentation date and time: April 17, 2024, 2:00pm ETLocation: Virtual Oppenheimer 9th Annual Emerging Growth ConferenceDate: May 9, 2024Location: Virtual JP Morgan Virtual Battery SeriesPresentation date and time: May 15, 2024, 10:00am ETLocation: Virtual TD Cowen’s 2nd...
Franklin Electric Schedules Its First Quarter 2024 Earnings Release an...
Franklin Electric Schedules Its First Quarter 2024 Earnings Release and Conference Call FORT WAYNE, Ind., April 16, 2024 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) will release its first quarter 2024 earnings at 8:00 am ET on Tuesday, April 30, 2024. A conference call to review earnings and other developments in the business will commence at 9:00 am ET. The first quarter 2024 earnings call will be available via a live webcast. The webcast will be available in a listen only mode by going to: For those interested in participating in the question-and-answer portion of ...
Xtep International Holdings Ltd: 1 director
A director at Xtep International Holdings Ltd bought 1,457,500 shares at 4.445HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
VEON to release 1Q 2024 trading update on 16 May 2024
VEON to release 1Q 2024 trading update on 16 May 2024 VEON to release 1Q 2024 trading update on 16 May 2024 Amsterdam, 16 April 2024 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, today confirms that the Group will release its selected financial and operating results for the first quarter ended 31 March 2024, at or around 7:00 CEST (6:00 BST, 1:00 EST) on 16 May 2024. VEON will also host a results conference call with senior management at 14:00 CEST (13:00 BST, 8:00 EST) on the same da...
Right on Brands Announces Major Product Line Expansion via HONEY® Bran...
Right on Brands Announces Major Product Line Expansion via HONEY® Brands DALLAS, April 16, 2024 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC company and a leading developer of a diverse range of hemp-based and THCA products, today announced a major expansion in its products line offered to Texas consumers. Via its recently formed majority owned subsidiary, California’s Best Products, Inc, the Company will begin marketing the super-premium products of HONEY® Brands throughout its growing network of retailers. “The addition of HONEY® branded products in...
Decklar to Apply for Management Cease Trade Order
Decklar to Apply for Management Cease Trade Order CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) -- Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the “Company” or “Decklar”) announces that it intends to apply to the Alberta Securities Commission, (the “ASC”), under National Policy 12-203 - Management Cease Trade Orders (“NP 12-203”) requesting that a temporary management cease trade order (“MCTO”) be granted in respect of the late filing of the consolidated audited financial statements, management’s discussion & analysis and related officer certifications and its annual...
Prosafe SE: Notice of Annual General Meeting to be held on 7 May 2024
Prosafe SE: Notice of Annual General Meeting to be held on 7 May 2024 The Annual General Meeting of Prosafe SE will be held on 7 May 2024 at 08.30 a.m. CEST. The meeting will be held as a virtual meeting only, with no physical attendance for shareholders. Live virtual attendance will take place via Lumi AGM. Shareholders who want to participate online do not need to pre-register but must be logged in before the meeting starts. Link to Lumi AGM: Participants will need to identify themselves using their unique reference number and PIN code assigned by the Norwegian Central Securities Dep...
ISC to Release 2024 First Quarter Financial Results on May 7, 2024
ISC to Release 2024 First Quarter Financial Results on May 7, 2024 REGINA, Saskatchewan, April 16, 2024 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) advises that it will release its financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after market close. ISC’s Unaudited Condensed Consolidated Interim Financial Statements and Notes and Management’s Discussion and Analysis for the first quarter ended March 31, 2024 will be available on SEDAR+ at and our website at . An investor conference call will be held on Wedne...
Provectus Biopharmaceuticals Announces Management Additions and Reiter...
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President KNOXVILLE, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced additions to its executive leadership team, reflecting Provectus's dedication to enhancing shareholder value. The Company’s Board of Directors (the “Board”) has appointed Ed Pershing as Chief Executive Officer (“CEO”) and Dominic Rodrigues ...
Incannex Healthcare Inc. Quarterly Update, Q1 2024
Incannex Healthcare Inc. Quarterly Update, Q1 2024 MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Inc. (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide quarterly activities update and for the quarter ended 31 March 2024. Incannex is undertaking various U.S. Food and Drug Administration (‘FDA’) research and development (‘R&D’) programs for cannabinoid pharmaceutical products and psychedelic medicine therapies. The nearest-to-market projects in the Company’s therapeutic pipeline are: IHL-4...
PainReform Announces Pricing of $4 Million Public Offering
PainReform Announces Pricing of $4 Million Public Offering TEL AVIV, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the pricing of a public offering of an aggregate of 5,000,000 of the Company’s ordinary shares (or ordinary share equivalents) and warrants to purchase up to 5,000,000 ordinary shares at a combined public offering price of $0.80 per share (or per ordinary share equivalent) and accompanying warrant. The warran...
Greif Prepares For Opening of New Manufacturing Facility in Dallas, Te...
Greif Prepares For Opening of New Manufacturing Facility in Dallas, Texas DALLAS, April 16, 2024 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, is finalizing construction on their new bulk corrugated manufacturing facility in Dallas, Texas. Scheduled to open later this spring, the new facility will significantly expand Greif's capacity in the bulk corrugated business and create opportunities in the South and Southwest regions of the United States, as well as Mexico. "We are delighted to establish this new facility in Da...
IPG Photonics to Announce First Quarter 2024 Financial Results on Apri...
IPG Photonics to Announce First Quarter 2024 Financial Results on April 30 MARLBOROUGH, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IPGP) will release its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024. The Company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived in the investor relations section of the Company’s website at . About IPG Ph...
LGI Homes Opens its First Community in St. Cloud, Minnesota Market
LGI Homes Opens its First Community in St. Cloud, Minnesota Market MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced that it has opened in the St. Cloud, Minnesota market with its new community, . Homeowners will enjoy the charm of small-town living paired with quick and convenient access to incredible big-city amenities. “We are excited to be in the St. Cloud market for the first time with our Parkside community located just 15 minutes from downtown St. Cloud. We offer customers brand-new, affordable homes with easy access to both St. C...
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Opt...
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that it has filed a provisional patent application pertaining to the recent advancements and optimizations Monopar has achieved with its MNPR-101 radiopharmaceutical program. The provisional patent titled “Antibody Radioisotope Constructs” that was filed with the United States Patent...
Absci to Report Business Updates and First Quarter 2024 Financial and ...
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 VANCOUVER, Wash. and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the first quarter before market open on Tuesday, May 14, 2024. Absci management will webcast a corresponding conference call beginning at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time to discuss its business developments, financial a...
Certara Launches Cloud Platform to Further Unify its End-to-End Scient...
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform PRINCETON, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to modeling and analysis of clinical trial results. "This reusable suite of shared platform services enables us to bo...
Asia Broadband Doubles Gold Production In 1st Quarter, Prior To Ore St...
Asia Broadband Doubles Gold Production In 1st Quarter, Prior To Ore Stockpile Processing Plant Completion LAS VEGAS, April 16, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the financial results for the 1st quarter ending March 31, 2024, will be published in the coming weeks confirming the Company’s increased production and gross profit. Gold production more than doubled in the 1st quarter of 2024, in comparison to the 4th quarter of 2023, due to the higher grade recoveries and increased daily throughput levels. Additionally...
New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-1...
New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion Data Presented at the American College of Cardiology Scientific Sessions; Research Letter Published in the Prestigious American Heart Journal Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces two new studies validating the clinical benefits of blood volume analysis (BVA) as a more precise measurement of congestion in ambulatory heart failure (HF)...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.